PT1309610E - Derivados de péptidos e miméticos de péptidos com propriedades de inibição da integrina ii - Google Patents

Derivados de péptidos e miméticos de péptidos com propriedades de inibição da integrina ii Download PDF

Info

Publication number
PT1309610E
PT1309610E PT01960611T PT01960611T PT1309610E PT 1309610 E PT1309610 E PT 1309610E PT 01960611 T PT01960611 T PT 01960611T PT 01960611 T PT01960611 T PT 01960611T PT 1309610 E PT1309610 E PT 1309610E
Authority
PT
Portugal
Prior art keywords
arg
lys
sup
gln
ile
Prior art date
Application number
PT01960611T
Other languages
English (en)
Inventor
Nies Dr Berthold
Michel Dard
Gabor Sulyok
Guenter Hoelzemann
Martin Kantlehner
Joerg Meyer
Horst Kessler
Ulrich Hersel
Christoph Gibson
Original Assignee
Biomet Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomet Deutschland Gmbh filed Critical Biomet Deutschland Gmbh
Publication of PT1309610E publication Critical patent/PT1309610E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/10—Process efficiency
PT01960611T 2000-08-17 2001-08-02 Derivados de péptidos e miméticos de péptidos com propriedades de inibição da integrina ii PT1309610E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10040103A DE10040103A1 (de) 2000-08-17 2000-08-17 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II

Publications (1)

Publication Number Publication Date
PT1309610E true PT1309610E (pt) 2009-03-16

Family

ID=7652667

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01960611T PT1309610E (pt) 2000-08-17 2001-08-02 Derivados de péptidos e miméticos de péptidos com propriedades de inibição da integrina ii

Country Status (17)

Country Link
US (1) US7276482B2 (pt)
EP (1) EP1309610B1 (pt)
JP (1) JP4795620B2 (pt)
KR (1) KR20030062318A (pt)
CN (1) CN1446230A (pt)
AT (1) ATE419269T1 (pt)
AU (1) AU2001282058A1 (pt)
CA (1) CA2419469C (pt)
CY (1) CY1108945T1 (pt)
CZ (1) CZ2003719A3 (pt)
DE (2) DE10040103A1 (pt)
DK (1) DK1309610T3 (pt)
ES (1) ES2317926T3 (pt)
MX (1) MXPA03001427A (pt)
PL (1) PL366312A1 (pt)
PT (1) PT1309610E (pt)
WO (1) WO2002014350A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001221607A1 (en) 2000-11-20 2002-05-27 Ecole Polytechnique Federale De Lausanne (Epfl) Endosseous implant
DE10325049A1 (de) * 2003-06-02 2004-12-23 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012727A1 (en) * 1991-01-25 1992-08-06 Regents Of The University Of Minnesota Laminin a chain domain vi polypeptides
DE19755801A1 (de) * 1997-12-16 2000-06-21 Merck Patent Gmbh Mit die Zelladhäsion vermittelnden Peptiden beschichtete Implantate und Verfahren zu ihrer Herstellung
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
DE19755800A1 (de) * 1997-12-16 1999-06-17 Merck Patent Gmbh Cyclopeptidderivate
DE19831710A1 (de) 1998-07-15 2000-01-20 Merck Patent Gmbh Diacylhydrazinderivate
DE19932796A1 (de) 1999-07-14 2001-01-18 Merck Patent Gmbh Diacylhydrazinderivate

Also Published As

Publication number Publication date
PL366312A1 (en) 2005-01-24
WO2002014350A2 (de) 2002-02-21
DK1309610T3 (da) 2009-03-30
CY1108945T1 (el) 2014-07-02
MXPA03001427A (es) 2003-06-06
AU2001282058A1 (en) 2002-02-25
JP2004506649A (ja) 2004-03-04
CZ2003719A3 (cs) 2003-06-18
WO2002014350A3 (de) 2002-09-19
JP4795620B2 (ja) 2011-10-19
CA2419469A1 (en) 2003-02-14
US7276482B2 (en) 2007-10-02
CN1446230A (zh) 2003-10-01
DE10040103A1 (de) 2002-02-28
EP1309610B1 (de) 2008-12-31
DE50114621D1 (de) 2009-02-12
EP1309610A2 (de) 2003-05-14
ATE419269T1 (de) 2009-01-15
KR20030062318A (ko) 2003-07-23
ES2317926T3 (es) 2009-05-01
CA2419469C (en) 2013-05-14
US20040043937A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
MY129408A (en) Disubstituted bicyclic, heterocycles, the preparation and the use thereof as pharmaceutical compositions
CA2211668A1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
GB0019359D0 (en) Novel guanidines
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
IL157179A0 (en) Fused heterocyclic compounds
CA2385995A1 (en) Quinuclidine compound and medicament comprising the compound as active ingredient
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
DE60130023D1 (de) Behandlung der nebenwirkungen von statinen
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
WO2006027798A3 (en) A process for preparation of an antidepressant compound
AU2001282059A1 (en) Peptide and peptide mimetic conjugates with integrin-inhibitor properties
EP1077218A3 (en) Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
NZ514576A (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
CY1108945T1 (el) Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι
DE69832376D1 (de) 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten
NZ515025A (en) Solvates of pymetrozine
AU2003273728A1 (en) A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
WO2000039087A3 (en) Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
TR200200614T2 (tr) Vitronektin reseptörü antagonistleri
WO2019040517A1 (en) CHIMERIC PEPTIDE FOR BIOMIMETIC IMPLANT INTERFACE
PL322969A1 (en) Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them
MX2008000497A (es) Compuestos precursores antiarritmicos, metodos de sintesis y metodos de uso.
GR3023144T3 (en) Inhibitors of pneumocystis carinii dihydrofolate reductase
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom